Financhill
Sell
39

CTCX Quote, Financials, Valuation and Earnings

Last price:
$0.23
Seasonality move :
-12.38%
Day range:
$0.20 - $0.23
52-week range:
$0.20 - $4.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.1M
Avg. volume:
518.7K
1-year change:
-94.05%
Market cap:
$4.8M
Revenue:
--
EPS (TTM):
-$0.30
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $982.8K $2.2M $2.5M
Selling, General & Admin -- -- $863.3K $3.2M $2.6M
Other Inc / (Exp) -- -- -$2M $205.5K -$10.1M
Operating Expenses -- -- $1.9M $5.5M $5.2M
Operating Income -- -- -$1.9M -$5.5M -$5.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$6.5M -$9.1M -$16.2M
Earnings of Discontinued Ops. -- -- -- -- $760.2K
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -$6.5M -$9.1M -$15.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$6.5M -$9.1M -$15.4M
 
Basic EPS (Cont. Ops) -- -- -$3.86 -$5.47 -$1.46
Diluted EPS (Cont. Ops) -- -- -$3.86 -$5.47 -$1.46
Weighted Average Basic Share -- -- $1.8M $1.8M $11M
Weighted Average Diluted Share -- -- $1.8M $1.8M $11M
 
EBITDA -- -- -$3.7M -$5.1M -$15.2M
EBIT -- -- -$4M -$5.3M -$15.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -$1.9M -$5.5M -$5.2M
Operating Income (Adjusted) -- -- -$4M -$5.3M -$15.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $3.7M $20.5K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $4.8K
Gross Profit -- -- -- -- $15.7K
Gross Profit Margin -- -- -- -- 76.41%
 
R&D Expenses -- -- $570.9K $1.6M $331.8K
Selling, General & Admin -- -- $257.4K $508K $1.1M
Other Inc / (Exp) -- -- -$3.7M -$6.6M -$1.5M
Operating Expenses -- -- $851.9K $2.1M $1.4M
Operating Income -- -- -$851.9K -$2.1M -$1.4M
 
Net Interest Expenses -- -- -- -- $7.1K
EBT. Incl. Unusual Items -- -- -$6.1M -$9.1M -$2.9M
Earnings of Discontinued Ops. -- -- -- -$2.4M --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$11.5M -$2.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$6.1M -$11.5M -$2.9M
 
Basic EPS (Cont. Ops) -- -- -$3.51 -$0.62 -$0.14
Diluted EPS (Cont. Ops) -- -- -$3.51 -$0.62 -$0.14
Weighted Average Basic Share -- -- $1.8M $18.6M $20.9M
Weighted Average Diluted Share -- -- $1.8M $18.6M $20.9M
 
EBITDA -- -- -$4.6M -$8.7M -$2.8M
EBIT -- -- -$4.6M -$8.7M -$2.9M
 
Revenue (Reported) -- -- -- $3.7M $20.5K
Operating Income (Reported) -- -- -$851.9K -$2.1M -$1.4M
Operating Income (Adjusted) -- -- -$4.6M -$8.7M -$2.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $3.8M $207.6K
Selling, General & Admin -- -- -- $3.8M $4.1M
Other Inc / (Exp) -- -- -$3.5M -$10.4M -$5.4M
Operating Expenses -- -- -- $7.7M $4.4M
Operating Income -- -- -- -$7.7M -$4.3M
 
Net Interest Expenses -- -- -- -- $16.5K
EBT. Incl. Unusual Items -- -- -- -$19.3M -$9.7M
Earnings of Discontinued Ops. -- -- -- -$2.4M $3.4M
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- -$7.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$21.7M -$6.3M
 
Basic EPS (Cont. Ops) -- -- -- -$4.08 -$0.30
Diluted EPS (Cont. Ops) -- -- -- -$4.08 -$0.30
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -$17.9M -$9.5M
EBIT -- -- -- -$18.1M -$9.7M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$7.7M -$4.3M
Operating Income (Adjusted) -- -- -- -$18.1M -$9.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $3.7M $32.8K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $5.1K
Gross Profit -- -- -- -- $27.7K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $570.9K $3.2M $865.3K
Selling, General & Admin -- -- $543.3K $1.7M $3.1M
Other Inc / (Exp) -- -- -$3.5M -$10.4M -$5.7M
Operating Expenses -- -- $1.1M $4.9M $4M
Operating Income -- -- -$1.1M -$4.9M -$4M
 
Net Interest Expenses -- -- -- -- $16.4K
EBT. Incl. Unusual Items -- -- -$6.1M -$16.2M -$9.7M
Earnings of Discontinued Ops. -- -- -- -$2.4M $282.2K
Income Tax Expense -- -- $266.4K -- --
Net Income to Company -- -- -- -$18.6M -$11M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$6.4M -$18.6M -$9.5M
 
Basic EPS (Cont. Ops) -- -- -$3.70 -$2.13 -$0.44
Diluted EPS (Cont. Ops) -- -- -$3.70 -$2.13 -$0.44
Weighted Average Basic Share -- -- $3.5M $39.6M $64.6M
Weighted Average Diluted Share -- -- $3.5M $39.6M $64.6M
 
EBITDA -- -- -$4.8M -$15.2M -$9.5M
EBIT -- -- -$4.9M -$15.3M -$9.7M
 
Revenue (Reported) -- -- -- $3.7M $32.8K
Operating Income (Reported) -- -- -$1.1M -$4.9M -$4M
Operating Income (Adjusted) -- -- -$4.9M -$15.3M -$9.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $12.4K $128.2K $2.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $55.1K $761.3K
Other Current Assets -- -- -- $28.2K --
Total Current Assets -- -- $178.7K $605.5K $62.9M
 
Property Plant And Equipment -- -- $1.3M $1.1M $1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- $33.2K $28.7K $24.2K
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- $1.6M $1.7M $63.9M
 
Accounts Payable -- -- $871.3K $2.1M $4.4M
Accrued Expenses -- -- $1.9M $505.4K $1.5M
Current Portion Of Long-Term Debt -- -- $8.6M $2.8M $1.3M
Current Portion Of Capital Lease Obligations -- -- $120.2K $129.5K $150.1K
Other Current Liabilities -- -- $3.8M $827K $29.9M
Total Current Liabilities -- -- $15.8M $7.3M $38.5M
 
Long-Term Debt -- -- $920 -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $31.1M $39.5M $39.2M
 
Common Stock -- -- $36.9K $900 $2.3K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -$29.6M -$37.8M $24.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -$29.6M -$37.8M $24.7M
 
Total Liabilities and Equity -- -- $1.6M $1.7M $63.9M
Cash and Short Terms -- -- $12.4K $128.2K $2.9M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $8M $1.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $14.4M $15.1K
Inventory -- -- -- $9.8M $97.9K
Prepaid Expenses -- -- -- $1.3M $430K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $38.9M $1.9M
 
Property Plant And Equipment -- -- -- $1.2M $536.2K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- $19.3M --
Other Intangibles -- -- -- $22.9M $20.8K
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $82.2M $2.4M
 
Accounts Payable -- -- -- $17.8M $4.2M
Accrued Expenses -- -- -- $3.7M $1.5M
Current Portion Of Long-Term Debt -- -- -- $7.3M $363K
Current Portion Of Capital Lease Obligations -- -- -- $140.8K $86.2K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $37.7M $6.2M
 
Long-Term Debt -- -- -- $1.5M --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $61.3M $6.5M
 
Common Stock -- -- -- $2.3K $2.1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $20.9M -$4.1M
 
Total Liabilities and Equity -- -- -- $82.2M $2.4M
Cash and Short Terms -- -- -- $8M $1.1M
Total Debt -- -- -- -- $363K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -$6.5M -$9.1M -$15.4M
Depreciation & Amoritzation -- -- $242.1K $242.6K $124.8K
Stock-Based Compensation -- -- $246.8K $636.4K $667.7K
Change in Accounts Receivable -- -- -- -- -$204.6K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$1.2M -$3.4M -$8.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$7.3K -$7.2K -$30.5K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $1.1M $2.7M $1.9M
Long-Term Debt Repaid -- -- -- -- -$3.2M
Repurchase of Common Stock -- -- -- -$2.3K --
Other Financing Activities -- -- -$166.3K -$402.6K $12.5M
Cash From Financing -- -- $1.2M $3.6M $11.2M
 
Beginning Cash (CF) -- -- $1.2K $12.4K $128.2K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $11.2K $115.8K $2.8M
Ending Cash (CF) -- -- $12.4K $128.2K $2.9M
 
Levered Free Cash Flow -- -- -$1.2M -$3.4M -$8.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$11.5M -$2.9M
Depreciation & Amoritzation -- -- -- -$54.1K $42.9K
Stock-Based Compensation -- -- -- $237.8K $185.7K
Change in Accounts Receivable -- -- -- $28.2K -$15.1K
Change in Inventories -- -- -- -- $16K
Cash From Operations -- -- -- -$4M -$1.4M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $1M $464.2K
Long-Term Debt Repaid -- -- -- -$2.8M -$122.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $12.8M --
Cash From Financing -- -- -- $11.1M $341.7K
 
Beginning Cash (CF) -- -- -- $15.9K $2.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $7.1M -$1.1M
Ending Cash (CF) -- -- -- $7.1M $1.1M
 
Levered Free Cash Flow -- -- -- -$4M -$1.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$7.8M
Depreciation & Amoritzation -- -- -- -- $215.7K
Stock-Based Compensation -- -- -- $605.3K $623.2K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$7M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- -$748.8K
Cash From Investing -- -- -- -- -$748.8K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $495.7K
Long-Term Debt Repaid -- -- -- -- -$1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $1.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- -$6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$18.6M -$11M
Depreciation & Amoritzation -- -- -- $67.9K $158.7K
Stock-Based Compensation -- -- -- $605.3K $560.9K
Change in Accounts Receivable -- -- -- $28.2K -$15.1K
Change in Inventories -- -- -- -- -$97.9K
Cash From Operations -- -- -- -$4.9M -$3.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- -$748.8K
Cash From Investing -- -- -- -$30.5K -$748.8K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $1.9M $495.7K
Long-Term Debt Repaid -- -- -- -$2.8M -$592.4K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $12.8M --
Cash From Financing -- -- -- $11.9M $2.6M
 
Beginning Cash (CF) -- -- -- $171.3K $6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $7M -$1.8M
Ending Cash (CF) -- -- -- $7.1M $4.2M
 
Levered Free Cash Flow -- -- -- -$5M -$3.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock